Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
6th grade Avg
|
New words:
ago, Anderson, antagonist, approve, approved, array, Arthur, brain, CABG, catalytic, cell, Certificate, chemotherapy, CPB, disclosed, earliest, evaluation, factor, final, fourth, growth, inclusion, independent, IPRD, label, leukemia, LLP, MI, open, opportunity, partially, Pending, pexelizumab, platelet, preclinical, prodrug, ratified, receipt, refundable, release, subset, tumor, webcast, website, wide
Removed:
anticipate, defined, existing, guidance, system
Filing tables
Filing exhibits
ALXN similar filings
External links